CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2020-09-29 | Huang Jane CMO, Hematology | Sale | −200 | $274.42 | $55K | 1,300 |
| 2020-09-29 | Huang Jane CMO, Hematology | Sale | −730 | $280.65 | $205K | 570 |
| 2020-09-29 | Huang Jane CMO, Hematology | Sale | −468 | $281.75 | $132K | 102 |
| 2020-09-29 | Huang Jane CMO, Hematology | Sale | −102 | $283.83 | $29K | 0 |
| 2020-09-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 383,075 | ||
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −450 | $272.74 | $123K | 22,853 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −550 | $274.08 | $151K | 22,303 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −200 | $274.42 | $55K | 22,103 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −400 | $276.88 | $111K | 21,703 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −800 | $278.92 | $223K | 20,903 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −3,831 | $280.30 | $1.1M | 17,072 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −10,827 | $281.16 | $3.0M | 6,245 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −4,236 | $282.05 | $1.2M | 2,009 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −1,609 | $283.11 | $456K | 400 |
| 2020-09-29 | OYLER JOHN Chief Executive Officer | Sale | −400 | $283.80 | $114K | 0 |
| 2020-09-28 | OYLER JOHN Chief Executive Officer | Sale | −2,233 | $278.50 | $622K | 28,767 |
| 2020-09-28 | OYLER JOHN Chief Executive Officer | Sale | −5,187 | $279.24 | $1.4M | 23,580 |
| 2020-09-28 | OYLER JOHN Chief Executive Officer | Sale | −21,080 | $280.26 | $5.9M | 2,500 |
| 2020-09-28 | OYLER JOHN Chief Executive Officer | Sale | −1,800 | $281.04 | $506K | 700 |
Page 78 of 99 · 1,972 trades